< 1 minute read
Feb. 9, 2022

KB-0742: an Ultraselective Inhibitor of Cyclin-Dependent Kinase CDK9

Kronos CDK9 Inhibitor

selective CDK9 inhibitor oral Ph. I candidate for MYC-amp tumors from microarray binding assay with lysate KB-0742 Kronos Bio, Cambridge, MA

twitterlinkedinprintemail

Molecules of the Month

MOTY Nominees

Molecule of the Year